Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | 0.00% | 0.00% | +2.04% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.04% | 20.26M | |
+12.06% | 101B | |
-0.62% | 30.04B | |
+12.05% | 21.97B | |
-16.05% | 17.86B | |
-6.34% | 17.46B | |
+8.74% | 15.04B | |
-4.89% | 12.09B | |
-2.85% | 10.26B | |
-8.86% | 8.8B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Unit, ENSCO Sign Drone Acquisition Deal